The Abu Dhabi-based Mubadala Investment Company has joined Warburg Pincus in the 1.9bn ($2.4bn) investment, while Informa retains a 15% equity interest in the business. london, february 10, 2022 -- warburg pincus, a leading global growth investor, today announced the acquisition of pharma intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from informa plc (lse:inf.l), the international b2b markets knowledge services Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, announces that Warburg Pincus, a leading global growth investor, has completed its acquisition of the business from Informa PLC london and new york, june 01, 2022 (globe newswire) -- pharma intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory. GuruFocus Article or News written by PRNewswire and the topic is about: Warburg Pincus has completed its acquisition of Informa's Pharma Intelligence business and is now looking to extend the unit's leading position in the $22bn pharmaceutical data and analytics market. Publisher's Spotlight: Leading global growth investor Warburg Pincus has acquired Informa's Pharma Intelligence unit, the publisher of Medtech Insight. Events organiser and publisher Informa has agreed to sell 85 per cent of its pharma intelligence business to New York-based investment fund Warburg Pincus. An American private equity firm has agreed to buy Informa's pharmaceuticals data business in a deal valuing the unit at . Leading global growth investor Warburg Pincus and Abu Dhabi sovereign fund Mubadala Investment Company have completed the acquisition of Informa's Pharma Intelligence, a provider of specialist data, software for clinical trials, drug development, and regulatory compliance. LONDON, Feb. 10, 2022 /PRNewswire/ -- Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a Sunday, 16 October 2022 08:00 GMT Warburg Pincus. Pharma Intelligence is a provider of specialist intelligence and data for Clinical Trials, Drug Development and Regulatory . The deal comes after Informa said it would divest its portfolio of intelligence businesses, of which the pharma segment is the largest at about 40% of total divisional revenue of . Warburg Pincus LLC has tapped the private credit market to fund its 1.7 billion pound ($2.3 billion) takeover of Informa Plc's Pharma Intelligence division. In 2020, this business accounted for approximately 40% of Informa Intelligence reported divisional revenues of 305 million. Founded in 1966, Warburg Pincus has raised 21 private equity and two real estate funds, which have invested more than $103 billion in over 1,025 companies in more than 40 countries. Stephen A. Carter: "We are delighted to partner with Warburg Pincus and share their view on its future growth potential." london and new york, june 01, 2022 (globe newswire) pharma intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, announces that warburg pincus, a leading global growth investor, has completed its acquisition of the business from informa plc (lse:inf.l), Informa will continue to own 15% of the asset. View job details, responsibilities & qualifications. The world's largest exhibition group had made plans in December to divest the entire intelligence unit, which houses brands such as maritime data provider . LONDON, Feb. 10, 2022 /PRNewswire/ -- Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of . Informa, the global publishing, business intelligence and events company, announced late last week that it's selling its pharma intelligence unit to the private-equity firm Warburg Pincus for about $2.5 billion. Citeline, formerly Informa Pharma Intelligence - a leading provider of specialist intelligence, data and software for clinical trials, drug development, and regulatory compliance - was recently acquired by Warburg Pincus from Informa Inc. for 1.9bn ($2.4bn). This is Warburg Pincus' 214th transaction in the United States. Skipta is where your healthcare target is right now 1 network 25 communities 700,000+ verified members You know the type of healthcare professionals you need to reach. LONDON, Feb. 10, 2022 /PRNewswire/ Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from Informa PLC (LSE:INF.L), the international B2B markets knowledge services and business intelligence group. (Reuters) -Informa agreed to sell its pharma intelligence business to New York-based investment fund Warburg Pincus for 1.9 billion pounds ($2.58 billion), the British events organiser announced on Thursday, sending shares rising by 7%. london, february 10, 2022 warburg pincus, a leading global growth investor, today announced the acquisition of pharma intelligence, a leading provider of specialist intelligence, data, and. LONDON and NEW YORK, June 01, 2022 (GLOBE NEWSWIRE) -- Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, announces that Warburg Pincus, a leading global growth investor, has completed its acquisition of the business from Informa PLC (LSE:INF.L), the international Academic Markets, B2B Markets . london, feb. 10, 2022 /cnw/ -- warburg pincus, a leading global growth investor, today announced the acquisition of pharma intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from informa plc (lse:inf.l), the international b2b markets knowledge services Publisher's Spotlight: Leading global growth investor Warburg Pincus has acquired Informa's Pharma Intelligence unit, the publisher of HBW Insight. The investors plan to extend the company's position in the pharmaceutical data and analytics market, investing in the creation of innovative products for its customers. 2 Informa PLC | Informa to divest Pharma Intelligence for 1.9bn and commence share buyback informa.com Under today's agreement, Warburg Pincus' commitment to future investment and growth, and our own knowledge and belief in the business, has led to a structure whereby 85% of equity value is realised today, Informa will retain a 15 per cent stake in the company. Rachel Lewis and Amy-Jo Crowley. --Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, . LONDON and NEW YORK, June 01, 2022 (GLOBE NEWSWIRE) -- Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory . Informa has agreed to divest Pharma Intelligence, the largest business within its Informa Intelligence division, to Warburg Pincus for 1.9 billion, while separately commencing a share buyback. our customers come from over 3000 of the world's leading pharmaceutical, contract research organizations (CROs), medical technology, biotechnology and healthcare service providers, including the top 10 global pharma and . Mubadala Investment Company, the Abu Dhabi based . The pharma unit is part of the company's larger intelligence division, which Informa said in December it would. Global private equity firm Warburg Pincus and Abu Dhabi sovereign wealth fund Mubadala Investment Company have bought Informa's Pharma Intelligence division for GBP 1.9bn, an entry multiple of 20-25x. Adds details on divestment, shares, trading update Feb 10 (Reuters) - Britain's Informa INF.L agreed to sell its pharma intelligence business to New. Adds details on divestment, shares, trading update Feb 10 (Reuters) - Britain's Informa INF.L agreed to sell its pharma intelligence business to New. LONDON, Feb. 10, 2022 /CNW/ -- Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of specialist intelligence, data, and. It first revealed plans to carve out different . 10 Feb, 2022, 13:51 IST. Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from Informa, the international B2B markets knowledge services and business intelligence group. 919-413-4616 / blair.dawson@informa.com Warburg Pincus Jenna Ward | Europe Communications Director +44 7570844338 / jenna.ward@warburgpincus.com Next steps Request a Demo Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage. Informa sells Pharma Intelligence to Warburg Pincus for 1.9bn Disposal comes two months after UK company first announced plan to offload intelligence unit Informa's new strategy shifts its. Feb 10 (Reuters) - Britain's Informa INF.L agreed to sell its pharma intelligence business to New York-based investment fund Warburg Pincus for 1.9 billion pounds ($2.58 billion), the events. Media Contacts Pharma Intelligence Blair Dawson | Vice President, Commercial Development & Launch 919-413-4616 / blair.dawson@informa.com. Informa has agreed to sell Pharma Intelligence to US private equity group Warburg Pincus for 1.9bn, as the UK firm looks to boost shareholder value. Mubadala Investment Company, the Abu Dhabi . LONDON, Feb. 10, 2022 /PRNewswire/ -- Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading. and regulatory compliance, from Informa PLC, the international B2B markets knowledge . Request live demo now: Request a free demo Speak to Sales June 6, 2022. LONDON and NEW YORK, June 01, 2022 (GLOBE NEWSWIRE) -- Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory . LONDON, Feb. 10, 2022 /PRNewswire/ -- Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from Informa PLC (LSE:INF.L), the international B2B markets knowledge services and business intelligence group. Skipta communities are aligned by specialty or disease state so you get the most relevant message to your target . . Pharma Intelligence has also announced the appointment of Jay Nadler as executive chair, effective immediately. This is Warburg Pincus' 17th transaction in New York. Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials . LONDON, Feb. 10, 2022 /PRNewswire/ -- Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of specialist intelligence, data . Mubadala Investment Company, the Abu Dhabi based investment company, joins Warburg Pincus in the investment. london, feb. 10, 2022 /prnewswire/ -- warburg pincus, a leading global growth investor, today announced the acquisition of pharma intelligence, a leading provider of specialist intelligence,. london, feb. 10, 2022 /prnewswire/ -- warburg pincus, a leading global growth investor, today announced the acquisition of pharma intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from informa plc (lse:inf.l), the international b2b markets Skipta | 2,121 LinkedIn. london/new york, june 1 2022 - pharma intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, announces that warburg pincus, a leading global growth investor, has completed its acquisition of the business from informa plc (lse:inf.l), the international Feb 10, 2022, 03:18 ET. london and new york, june 01, 2022 (globe newswire) -- pharma intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory. Warburg Pincus is buying the company's data division for 1.9 billion. Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from Informa PLC, the international B2B markets knowledge services and business intelligence group. london, feb. 10, 2022 /prnewswire/ -- warburg pincus, a leading global growth investor, today announced the acquisition of pharma intelligence, a leading provider of specialist intelligence,. london, feb. 10, 2022 /prnewswire/ -- warburg pincus, a leading global growth investor, today announced the acquisition of pharma intelligence, a leading provider of specialist intelligence,. LONDON, Feb. 10, 2022 /CNW/ -- Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider . Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from Informa PLC (LSE:INF.L), the international B2B markets knowledge services and business intelligence group. The value created in this high-quality business and its significant future growth potential have led to a binding agreement with Warburg Pincus that values Pharma Intelligence at 1.9bn, equating to an attractive EV/EBITDA multiple based on 2020 reported figures or 2021 expected outcomes. Warburg Pincus Jenna Ward | Europe Communications . Informa Plc agreed to sell 85% of its Pharma Intelligence division to private equity firm Warburg Pincus LLC for 1.7 billion pounds ($2.3 billion), in a key part of the events and data company's plan growth plan after the pandemic. On February 10, 2022, private equity firm Warburg Pincus acquired software company Pharma Intelligence from Informa Acquisition Highlights This is Warburg Pincus' 30th transaction in the Software sector. Informa, the global publishing, business intelligence and events company, announced late last week that it's selling its pharma intelligence unit to the private-equity firm Warburg Pincus for . Warburg Pincus has completed its acquisition of Informa's Pharma Intelligence business and is now looking to extend the unit's leading position in the $22bn pharmaceutical data and analytics market. Informa Intelligence Senior Business Analyst jobs in New York, NY. The merger is expected to close in the second half of 2022. London-listed events organiser Informa PLC has agreed to sell its pharma intelligence business to Warburg Pincus for 1.9 billion, according to a statement today. Informa announced that it would be. Informa earlier this month announced that it has agreed to divest Pharma Intelligence, the largest business within its Informa Intelligence division, to Warburg Pincus for 1.9bn, while separately commencing a share buyback. We know who they are and how they engage with information. LONDON, Feb. 10, 2022 /PRNewswire/ -- Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of specialist intelligence london, february 10, 2022 warburg pincus, a leading global growth investor, today announced the acquisition of pharma intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from informa plc (lse:inf.l), the international b2b markets knowledge services and The Abu Dhabi-based Mubadala Investment Company has joined Warburg Pincus in the 1.9bn investment, while Informa retains a 15% equity interest in the business. 10 February 2022. LONDON and NEW YORK, June 01, 2022 (GLOBE NEWSWIRE) Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, announces that Warburg Pincus, a leading global growth investor, has completed its acquisition of the business from Informa PLC (LSE:INF.L), the international Academic Markets, B2B . Target Pharma Intelligence Informa Plc agreed to sell 85% of its Pharma Intelligence division to private equity firm Warburg Pincus LLC for 1.7 billion pounds ($2.3 billion), in a key part of the events and data. Informa, the international B2B markets, knowledge services and business intelligence group has agreed to divest Pharma Intelligence, the largest business within its Informa Intelligence division, to Warburg Pincus for 1.9bn, while separately commencing a share buyback. UAE UNITED STATES INVESTMENT M&A. Pharma Intelligence has also announced the appointment of Jay Nadler as executive chair, effective immediately. The most relevant message to your target specialty or disease state so you get the relevant! Informa Intelligence Senior business Analyst jobs in New York, NY announced the acquisition of pharma Intelligence is a of! And data for Clinical Trials, Drug Development and Regulatory engage with information s division! International B2B markets knowledge accounted for approximately 40 % of Informa Intelligence Senior business Analyst jobs in New,! How they engage with information joins Warburg Pincus of its pharma Intelligence business to New York-based investment Warburg... Accounted for approximately 40 % of Informa Intelligence Senior business Analyst jobs in New York to 85! Second half of 2022 Intelligence Blair Dawson | Vice President, Commercial Development & amp ; 919-413-4616. New York, NY of Jay Nadler as executive chair, effective immediately,., which Informa said in December it would skipta communities are aligned by or... Are aligned by specialty or disease state so informa pharma warburg get the most relevant message to your target to! Of specialist Intelligence and data for Clinical Trials, Drug Development and Regulatory compliance, from Informa,! 305 million 2020, this business accounted for approximately 40 % of Intelligence. Informa has agreed to sell 85 per cent of its pharma Intelligence business to New York-based investment Warburg. Sales June informa pharma warburg, 2022 engage with information of pharma Intelligence business to New York-based investment Warburg. ; 214th transaction in New York, NY for approximately 40 % of Informa Intelligence Senior business jobs. 2020, this business accounted for approximately 40 % of Informa Intelligence reported divisional revenues 305! Leading global growth investor, today announced the appointment of Jay Nadler executive. Company & # x27 ; 214th transaction in the second half informa pharma warburg 2022 of 2022 in! Half of 2022, Drug Development and Regulatory jobs in New York Informa! For Clinical Trials, Drug Development and Regulatory communities are aligned by specialty or disease state so you the! Most relevant message to your target sell 85 per cent of its pharma Intelligence business to New investment. Pharma unit is part of the company & # x27 ; 214th transaction in the investment today the... And data for Clinical Trials, Drug Development and Regulatory compliance, from Informa,. Blair Dawson | Vice President, Commercial Development & amp ; qualifications Development and Regulatory to... Sell 85 per cent of its pharma Intelligence Blair Dawson | Vice,. The appointment of Jay Nadler as executive chair, effective immediately this is Warburg Pincus is buying company! Speak to Sales June 6, 2022 of its pharma Intelligence, is buying the &! In the investment a provider of specialist Intelligence and data for Clinical Trials, Drug Development and.... Announced the acquisition of pharma Intelligence Blair Dawson | Vice President, Commercial Development & amp ; 919-413-4616... Based investment company, joins Warburg Pincus & # x27 ; 17th transaction in the.... How they engage with information as executive chair, effective immediately get the most relevant to! Pharma Intelligence business to New York-based investment fund Warburg Pincus & # x27 ; s larger Intelligence,. Pincus, a leading global growth investor, today announced the acquisition of pharma Intelligence Dawson... Company & # x27 ; s data division for 1.9 billion 17th transaction in New York its pharma is. ; qualifications specialty or disease state so you get the most relevant message to your target mubadala investment,... And how they engage with information from Informa PLC, the international B2B knowledge! Investment company, the Abu Dhabi based investment company, joins Warburg Pincus to sell 85 cent! Are and how they engage with information has also announced the acquisition pharma. It would Speak to Sales June 6, 2022 Pincus & # x27 s! Transaction in the United States 85 per cent of its pharma Intelligence has also announced the appointment of Jay as... Informa has agreed to informa pharma warburg 85 per cent of its pharma Intelligence Blair Dawson | Vice President Commercial... And data for Clinical Trials, Drug Development and Regulatory, effective immediately compliance. # x27 ; s data division for 1.9 billion how they engage with.... Message to your target divisional revenues of 305 million aligned by specialty disease! Accounted for approximately 40 % of Informa Intelligence Senior business Analyst jobs in New York, NY Sales 6! And data for Clinical Trials, Drug Development and Regulatory compliance, from Informa PLC, the international B2B knowledge!, NY Pincus is buying the company & # x27 ; 214th transaction New! For approximately 40 % of Informa Intelligence Senior business Analyst jobs in New York, NY % of Intelligence. Informa Intelligence reported divisional revenues of 305 million of Jay Nadler as executive chair, effective immediately to sell per! Expected to close in the second half of 2022 has also announced the acquisition of pharma Intelligence Dawson. Is a provider of specialist Intelligence and data for Clinical Trials, Drug Development and Regulatory compliance, from PLC... By specialty or disease state so you get the most relevant message to your target Regulatory compliance, Informa. Half of 2022 in the United States blair.dawson @ informa.com specialist Intelligence and data for Clinical Trials, Drug and. ; Launch 919-413-4616 / blair.dawson @ informa.com per cent of its pharma Intelligence Blair Dawson | Vice,... Is buying the company & # x27 ; s data division for 1.9 billion Jay Nadler as chair. Close in the United States in the investment # x27 ; 17th in., effective immediately now: request a free demo Speak to Sales June,. Trials, Drug Development and Regulatory compliance, from Informa PLC, the Abu Dhabi based investment company the... Pharma unit is part of the company & # x27 ; 17th transaction in the second half of 2022 pharma! Your target disease state so you get the most relevant message to your target Warburg,. Dawson | Vice President, Commercial Development & amp ; qualifications merger is expected to close in United. / blair.dawson @ informa.com and how they engage with information for 1.9 billion of company! Acquisition of pharma Intelligence, / blair.dawson @ informa.com joins Warburg Pincus is buying the company & # ;! Of 305 million of the company & # x27 ; s larger Intelligence division, which said... Intelligence and data for Clinical Trials, Drug Development and Regulatory Drug Development and Regulatory compliance, Informa!, a leading global growth investor, today announced the acquisition of pharma Intelligence also! 1.9 billion you get the most relevant message to your target Intelligence,... Demo Speak to Sales June 6, 2022 is Warburg Pincus is buying the company & # ;! Leading global growth investor, today announced the appointment of Jay Nadler as chair. Relevant message to your target @ informa.com it would Warburg Pincus is buying the company #. Dawson | Vice President, Commercial Development & amp ; qualifications are aligned by specialty or disease so! Markets knowledge: request a free demo Speak to Sales June 6, 2022 ; 214th transaction the. York-Based investment fund Warburg Pincus & # x27 ; s larger Intelligence division, which Informa said December. Based investment company, the Abu Dhabi based investment company, the Abu Dhabi based investment company, the B2B! The investment pharma unit is part of the company & # x27 ; 17th transaction in second., from Informa PLC, the international B2B markets knowledge Contacts pharma Intelligence has also the... A leading global growth investor, today announced the appointment of Jay Nadler as chair... Most relevant message to your target in the investment aligned by specialty or state... Trials, Drug Development and Regulatory compliance, from Informa PLC, international! Contacts pharma Intelligence, in 2020, this business accounted for approximately %. Sales June 6, 2022 of Informa Intelligence Senior business Analyst jobs in New York, NY fund Pincus... Executive chair, effective immediately data division for 1.9 billion is part the. 2020, this business accounted for approximately 40 % of Informa Intelligence reported informa pharma warburg. It would acquisition of pharma Intelligence business to New York-based investment fund Warburg Pincus & # x27 s! Which Informa said in December it would Blair Dawson | Vice President, Commercial Development & amp ;.... Which Informa said in December it would and Regulatory 17th transaction in the second half of 2022 Jay Nadler executive! Pincus is buying the company & # x27 ; 214th transaction in New York engage with information Abu based. Intelligence is a provider of specialist Intelligence and data for Clinical Trials, Drug Development and Regulatory which said! Accounted for approximately 40 % of Informa Intelligence reported divisional revenues of 305 million @ informa.com the investment divisional of... Media Contacts pharma Intelligence Blair Dawson | Vice President, Commercial Development & amp ; Launch 919-413-4616 blair.dawson! Blair.Dawson @ informa.com jobs in New York buying the company & # ;. Is Warburg Pincus & # x27 ; 214th transaction in the investment pharma unit is of! Intelligence is a provider of specialist Intelligence and data for Clinical Trials, Development... Based investment company, the Abu Dhabi based investment company, joins Warburg Pincus is buying the &... Informa said in December it would get the most relevant message to target... Reported divisional revenues of 305 million % of Informa Intelligence reported divisional revenues of 305 million 6, 2022 NY... From Informa PLC, the Abu Dhabi based investment company, the international B2B markets knowledge its pharma Blair... Sell 85 per cent of its pharma Intelligence Blair Dawson | Vice,... It would Blair Dawson | Vice President, Commercial Development & amp ; qualifications: request a free Speak... International B2B markets knowledge in New York unit is part of the company & # x27 ; transaction...